RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

NCT00968253 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Acute Lymphocytic Leukemia

Interventions

DRUG: Everolimus (RAD001)
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Dexamethasone
DRUG: Mesna
DRUG: Methotrexate
DRUG: Ara-C (Cytarabine)
DRUG: Methylprednisone
DRUG: G-CSF

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]